Profound Medical
PROF
39 hedge funds and large institutions have $80.1M invested in Profound Medical in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 7 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.04% less ownership
Funds ownership: 39% → 38.96% (-0.04%)
0% less capital invested
Capital invested by funds: $80.4M → $80.1M (-$255K)
9% less funds holding
Funds holding: 43 → 39 (-4)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$1.24M |
| 2 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$564K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$452K |
| 4 |
Neuberger Berman Group
New York
|
+$109K |
| 5 |
RJT
Raymond James Trust
St. Petersburg,
Florida
|
+$84.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$1.05M |
| 2 |
ZDA
Zweig-DiMenna Associates
New York
|
-$889K |
| 3 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
-$263K |
| 4 |
GS
Gagnon Securities
New York
|
-$165K |
| 5 |
Renaissance Technologies
New York
|
-$160K |
PROF Hedge Fund Activity: Q2 2024 in Review
39 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2024, worth a combined $80.1M — down 0.32% from $80.4M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PROF and 4 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 13 added.
The largest buyer was Fidelity International, adding an estimated $1.24M. The largest seller was Timelo Investment Management, cutting an estimated $1.05M.
- 39 institutional investors held Profound Medical (PROF) as of Q2 2024, down from 43 in Q1 2024.
- Funds reported $80.1M of Profound Medical stock for Q2 2024, down 0.32% quarter-over-quarter.
- 4 funds opened new Profound Medical positions in Q2 2024 and 7 closed out, a net change of -3 holders.
- The largest Profound Medical buyer in Q2 2024 was Fidelity International, an estimated $1.24M added.
- The largest Profound Medical seller in Q2 2024 was Timelo Investment Management, an estimated $1.05M sold.
Based on aggregated 13F filings for Q2 2024.